Live from the NIH registry
Studies recruiting near Metairie right now
Top 25 of 531 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
Ochsner Health — Jefferson, Louisiana (2.6 mi)
· Sponsor: Astellas Pharma Inc
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Tandem Clinical Research - Metairie Clinic — Metairie, Louisiana (1.8 mi)
· Sponsor: Crystalys Therapeutics
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Omega Clinical Research — Metairie, Louisiana (1.8 mi)
· Sponsor: Novartis Pharmaceuticals
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
Emotional Distress, Prosocial Behavior
N/A
Interventional 800 participants sought
Coalition for Compassionate Schools — New Orleans, Louisiana (6.8 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Multicenter HomeVENT: Home Values and Experiences Navigation Track
Pediatric ALL, Respiratory Insufficiency
N/A
Interventional 600 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: Johns Hopkins University
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Obesity
N/A
Interventional 522 participants sought
InclusivCare - Kenner Clinic — Kenner, Louisiana (3.8 mi)
· Sponsor: Tulane University
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prostate Cancer
Phase 4
Interventional 700 participants sought
Tulane Cancer Center — New Orleans, Louisiana (6.8 mi)
· Sponsor: Novartis Pharmaceuticals
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (6.8 mi)
· Sponsor: Sellas Life Sciences Group
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Clinical Trials Management, LLC — Metairie, Louisiana (1.8 mi)
· Sponsor: Eli Lilly and Company
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — New Orleans, Louisiana (6.8 mi)
· Sponsor: AstraZeneca
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Interstitial Lung Disease
Phase 2
Interventional 25 participants sought
aTyr Investigative Site — New Orleans, Louisiana (6.8 mi)
· Sponsor: aTyr Pharma, Inc.
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 600 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: NRG Oncology
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (6.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Tulane University Health Sciences Center — New Orleans, Louisiana (6.8 mi)
· Sponsor: Incyte Corporation
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Tulane University — New Orleans, Louisiana (6.8 mi)
· Sponsor: Medical University of South Carolina
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (6.8 mi)
· Sponsor: Zucara Therapeutics Inc.
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Wounds and Injuries, Shock, Hemorrhagic
Phase 3
Interventional 1,100 participants sought
University Medical Center New Orleans LCMC Health — New Orleans, Louisiana (6.8 mi)
· Sponsor: University of Alabama at Birmingham
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
Phase 3
Interventional 720 participants sought
Research Site — Jefferson, Louisiana (2.6 mi)
· Sponsor: Arcus Biosciences, Inc.
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
Prostatic Neoplasms, Castration-Resistant
Phase 1, Phase 2
Interventional 54 participants sought
East Jefferson General Hospital — River Ridge, Louisiana (3.4 mi)
· Sponsor: Clarity Pharmaceuticals Ltd
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
East Jefferson General Hospital — Metairie, Louisiana (1.8 mi)
· Sponsor: National Cancer Institute (NCI)
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Chronic Low-back Pain, Vertebrogenic Pain Syndrome
N/A
Observational 1,500 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (6.8 mi)
· Sponsor: Boston Scientific Corporation
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
Phase 3
Interventional 800 participants sought
East Jefferson General Hospital — Metairie, Louisiana (1.8 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Clear Cell Renal Cell Carcinoma, Solid Tumors
Phase 1
Interventional 362 participants sought
Research Site — New Orleans, Louisiana (6.8 mi)
· Sponsor: Arcus Biosciences, Inc.
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
Phenylketonuria (PKU)
N/A
Observational 450 participants sought
Tulane University Medical Center — New Orleans, Louisiana (6.8 mi)
· Sponsor: BioMarin Pharmaceutical
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Tulane University School of Medicine — New Orleans, Louisiana (6.8 mi)
· Sponsor: National Cancer Institute (NCI)